Elicio Therapeutics Inc (FRA:9HA)
€ 2.8 (0%) Market Cap: 46.93 Mil Enterprise Value: 46.39 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 10/100

Elicio Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026 / 06:10 PM GMT
Release Date Price: €11.3 (-0.88%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ELTX.OQ - Elicio Therapeutics Inc
Elicio Therapeutics Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 06:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon everyone. Welcome.

Thank you for coming.

Our CEO Bob Connolly was meant to be here, but, because of a personal matter he wasn't able to join us. So brief intro. I'm Pete Demuth. I'm the CSO at Alysio and I'll be walking you through our slides for today.

We are a publicly traded company, so I'll just pause here for for looking statements and disclaimers.

All right. So, to start off with some brief highlights, Alysio is a lymph node targeted immunotherapy company, developing a suite of lymph node targeted immunotherapies for a variety of, cancer indications. These are intended to be off the shelf products. So, to give you a bit of background. That the technology is
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot